Cholesterol Changes in Coronary Patients after a Short Behavior Modification Program

International Journal of Behavioral Medicine

Volumn 10, Issue 4, 2003, Pages 315-330

  Sebregts, Ellen H ^a,b   Falger, Paul R ^a   Bär, Frits W ^a   Kester, Arnold D ^a   Appels, Ad ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MFE RIAGG Almelo   (Netherlands)

Author keywords

Behavior modification; Cholesterol; Coronary artery disease; Intervention

Indexed keywords

ACIPIMOX; ANTILIPEMIC AGENT; CHOLESTEROL; COLESTYRAMINE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BEHAVIOR MODIFICATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FAT INTAKE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0346749425     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327558IJBM1004_3     Document Type: Article

References (18)

1. Bracke, P. E., & Thoresen, C. E. (1996). Reducing type A behavior patterns: A structured-group approach. In R. Allen & S. Scheidt (Eds.), Heart & mind. The practice of cardiac psychology (pp. 255-290). Washington, DC: American Psychological Association.
2. Burell, G. (1996). Group psychotherapy in Project New Life: Treatment of coronary-prone behaviors for patients who have had coronary artery bypass graft surgery. In R. Allen & S. Scheidt (Eds.), Heart & mind. The practice of cardiac psychology (pp. 291-310). Washington, DC: American Psychological Association.
3. DeBusk, R. F., Houston Miller, N., Superko, R., Dennis, C. A., Thomas, R. J., Lew, H. T., et al. (1994). A case-management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine, 120, 721-729.
4. Engblom, E., Korpilahti, K., Hämäläinen, H., Puukka, P., & Rönnemaa, T. (1996). Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors. American Journal of Cardiology, 78, 1428-1431.
5. Falger, P. R. J. (1989). Life-span development and myocardial infarction: An epidemiological study. Unpublished doctoral dissertation, Maastricht University, Maastricht, The Netherlands.
6. Feunekes, G. I. J., Van Staveren, W. A., De Vries, J. H. M., Burema, J., & Hautvast, J. G. A. J. (1993). Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. American Journal of Clinical Nutrition, 38, 1-8.
7. Feunekes, I. J., Van Staveren, W. A., Graveland, F., De Vos, J., & Burema, J. (1995). Reproducibility of a semiquantitative food frequency questionnaire to assess the intake of fats and cholesterol in The Netherlands. International Journal of Food Sciences and Nutrition, 46, 117-123.
8. Niebauer, J., Hambrecht, R., Velich, T., Hauer, K., Marburger, C., Kälberer, B., et al. (1997). Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Role of physical exercise. Circulation, 96, 2534-2541.
9. Omish, D., Brown, S. E., Scherwitz, L. W., Billings, J. H., Armstrong, W. T., Ports, T. A., et al. (1990). Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. The Lancet, 336, 129-133.
10. Pfeffer, M. A., Sacks, F. M., & Moyé, L. A. (1999). Influence of baseline lipids on effectiveness of pravastatin in the CARE trial. Journal of the American College of Cardiology, 33, 125-130.
11. Sacks, F. M., Pfeffer, M. A., Moyé, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., et al. (1996). The effect of pravastatin on coronary events after myocardial infarction in patients with average choleterol levels. The New England Journal of Medicine, 335, 1001-1009.
12. Scandinavian Simvastatin Survival Study Group. (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). The Lancet, 344, 1383-1389.
13. Sebregts, E. H. W. J., Falger, P. R. J., & Bär, F. W. H. M. (2000). Risk factor modification through nonpharmacological interventions in patients with coronary heart disease. Journal of Psychosomatic Research, 48, 425-441.
14. Van Dixhoorn, J. (1997). Gunstige effecten van adem- en ontspanningsinstructie in de hartrevalidatie: Een gerandomiseerd follow-up onderzoek gedurende 5 jaar [Favorable effects of breathing and relaxation instructions in cardiac rehabilitation: A 5-year randomized follow-up study]. Nederlands Tijdschrift voor Geneeskunde, 141, 530-534.
15. Van Elderen, T., & Dusseldorp, E. (2001). Lifestyle effects of group health education for patients with coronary heart disease. Psychology and Health, 16, 327-341.
16. Wageningen University. (1993). VET Expres. Devoedselfrequentievragenlijst naar de vetconsumptie [A food frequency questionnaire estimating the intake of fats]. Wageningen, The Netherlands: Author.
17. Watts, G. F., Lewis, B., Brunt, J. N. H., Lewis, E. S., Coltart, D. J., Smith, L. D. R., et al. (1992). Effect: on coronary artery disease of lipid-lowering diet, of diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). The Lancet, 339, 563-569.
18. West of Scotland Coronary Prevention Study Group. (1998). Influence of pravastatin in and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 97. 1440-1445.